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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER2381Teamwork and Leadership in CPRSabina Hunziker, Anna C. Johansson, Franziska Tschan, Norbert K. Semmer, Laura Rock,
Michael D. Howell, Stephan Marsch
Despite substantial efforts to utilize cardiopulmonary resuscitation (CPR) algorithms, the
outcomes of CPR remain disappointing. Emerging evidence suggests that in addition to the
technical skills of individual rescuers, human factors such as teamwork and leadership affect
the efficacy of CPR. This review by Hunziker and colleagues describes research linking team
interactions to the performance of CPR. Most of this research comes from simulator studies,
which remove the clinical variables of the resuscitation, thus letting researchers study human
factors and team interactions. Teamwork and leadership training appear to improve team
performance and have recently been included in guidelines for advanced life support courses.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
2389SYNTAX Score Provides Prognostic Information
in Patients With Acute Coronary SyndromesTullio Palmerini, Philippe Genereux, Adriano Caixeta, Ecaterina Cristea, Alexandra Lansky,
Roxana Mehran, George Dangas, Dana Lazar, Raquel Sanchez, Martin Fahy, Ke Xu, Gregg W. Stone
Palmerini and colleagues investigated the predictive value of the SYNTAX score (SS) for
risk stratification in patients with non–ST-segment elevation acute coronary syndromes
(NSTEACS) who undergo percutaneous coronary intervention (PCI). Subjects were stratified
into tertiles of SS based on the original angiogram. By multivariable analysis, SS was an
independent predictor of 1-year death, cardiac death, myocardial infarction (MI), and target
vessel revascularization. SS impacted death, cardiac death, and MI both within the first
30 days after PCI and between 30 days and 1 year. In patients with NSTEACS undergoing
PCI, the SS provides robust prognostic information.(continued on page A-26)
JUNE 14, 2011 (continued) A-26BIOMARKERS2398Troponin T May Be Released With Ischemia, Rather Than Only With MyonecrosisAslan T. Turer, Tayo A. Addo, Justin L. Martin, Marc S. Sabatine, Gregory D. Lewis, Robert E. Gerszten,
Ellen C. Keeley, Joaquin E. Cigarroa, Richard A. Lange, L. David Hillis, James A. de Lemos
Turer and colleagues studied whether ischemia without necrosis would result in the release of
cardiac troponin T (cTnT). Patients were referred for diagnostic catheterization and rapid
atrial pacing with serial measurements of cTnT from the coronary sinus and peripheral blood.
cTnT concentrations were found to increase with pacing. Although peripheral cTnT
concentrations tended to be higher for patients with atherosclerosis and lactate elution, the
relative and absolute changes were similar for those with and without atherosclerosis. The
higher sensitivity of current-generation cTnT assays can detect ischemia, without frank
infarction, even among patients without atherosclerosis.Editorial Comment: Harvey D. White, p. 2406HEART FAILURE
2409Bone Marrow Mononuclear Cells Delivered
Through Graft Vessel During CABG May Improve OutcomesShengshou Hu, Sheng Liu, Zhe Zheng, Xin Yuan, Lihuan Li, Minjie Lu, Rui Shen, Fujian Duan,
Xiaoling Zhang, Jun Li, Xuewen Liu, Yunhu Song, Wei Wang, Shihua Zhao, Zuoxiang He, Hao Zhang,
Keming Yang, Wei Feng, Xin Wang
Bone marrow mononuclear cells (BMMNCs) are easy to harvest and have the potential to
improve heart function by inducing angiogenesis and myocardial regeneration. Hu and
colleagues hypothesized that delivering the cells into the vasculature during cardiac arrest
would improve their uptake and dispersal compared with direct intramyocardial injection.
Patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (CABG)
were randomized to autologous BMMNC infusion through the newly made bypass graft or
placebo. At 6 months, there were significant improvements in left ventricular ejection
fraction, left ventricular end-systolic volume index, wall motion score index, and 6-min
walking distance in patients assigned to BMMNC.(continued on page A-30)







2416Reverse Remodeling Reduces the Risk of
Ventricular Tachyarrhythmias in CRT PatientsAlon Barsheshet, Paul J. Wang, Arthur J. Moss, Scott D. Solomon, Amin Al-Ahmad, Scott McNitt,
Elyse Foster, David T. Huang, Helmut U. Klein, Wojciech Zareba, Michael Eldar, Ilan Goldenberg
Barsheshet and colleagues evaluated the relationship between echocardiographic response to
cardiac resynchronization therapy (CRT) and the risk of ventricular tachyarrhythmias (VTA).
The rates of VTA were compared between those who had echocardiographic remodeling,
defined as a 25% reduction in left ventricular end-systolic volume at 1 year, to those who
ad no response, and to those who received an implantable cardioverter-defibrillator (ICD)
nly in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac
esynchronization Therapy). The risk of VTA was lowest in echocardiographic responders
12%) followed by ICD-only patients (21%), and was highest among nonresponders (28%).
hese findings suggest that the process of reverse remodeling induced by CRT results in both
echanical and electrical stability of the left ventricle.ditorial Comment: Anne B. Curtis, p. 2424CARDIAC IMAGING2426Meta-Analysis of the Long-Term Prognostic Value of Coronary CT AngiographyFabian Bamberg, Wieland H. Sommer, Verena Hoffmann, Stephan Achenbach, Konstantin Nikolaou,
David Conen, Maximilian F. Reiser, Udo Hoffmann, Christoph R. Becker
Bamberg and colleagues conducted a systematic review and meta-analysis to determine the
predictive value of coronary computed tomography (CT) angiography for subsequent
cardiovascular events. A total of 11 eligible papers, including 7,335 participants, were
combined. The presence of 1 significant stenosis was associated with a 10-fold higher risk
of subsequent events including revascularization and a 6-fold higher risk of events excluding
revascularization. Further analysis revealed that the following findings influenced the
likelihood of subsequent events: 1) the presence of at least 1 coronary artery stenosis 50%
diameter; 2) the number of coronary segments with a stenosis 50%; 3) left main disease; 4)
the presence of any detectable atherosclerotic plaque, regardless of severity; and 5) the number
of segments containing any nonobstructive plaque, calcified, noncalcified, and mixed plaque.(continued on page A-31)
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Richard V. Williams, Roger E. Breitbart, Minmin Lu, Elizabeth Radojewski, Renee Margossian,
Wesley Covitz, Welton M. Gersony, for the Pediatric Heart Network Investigators
Creation of a systemic to pulmonary venous atrial level communication (fenestration) at the
time of a Fontan procedure may improve acute hemodynamics, but the long-term outcomes
have not been well described. Fenestration was performed in two-thirds of patients reviewed
by Atz and colleagues. After multivariable adjustment, the fenestrated group had a shorter
length of hospital stay. At a median of 8 years after Fontan, the fenestration remained open
in 19% of subjects, with 59% of those closed by catheter intervention and 40% with apparent
spontaneous closure. Functional health status, exercise performance, echocardiographic
variables, and risk of stroke or thrombosis did not differ in those with an open or closed
fenestration. These results confirm the early benefits of surgical fenestration and its long-term
safety.PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH
2444Gene Transfer and Progenitor Cell Mobilization
Improve Post-MI Recovery in a Mouse ModelJérôme Roncalli, Marie-Ange Renault, Jörn Tongers, Sol Misener, Tina Thorne, Christine Kamide,
Kentaro Jujo, Toshikazu Tanaka, Masaaki Ii, Ekaterina Klyachko, Douglas W. Losordo
Sonic hedgehog (Shh) gene transfer improves myocardial recovery by up-regulating
angiogenic genes and enhancing the incorporation of bone-marrow–derived progenitor cells
(BMPCs) in infarcted myocardium. In this report, Roncalli and colleagues investigated
whether the effectiveness of Shh gene therapy could be improved by inducing progenitor cell
mobilization from the bone marrow with AMD3100 in a mouse model. Mice were treated
with Shh, AMD3100, or both. Combination therapy enhanced cardiac functional recovery
(i.e., left ventricular ejection fraction) and was associated with less fibrosis, greater capillary
density, and enhanced BMPC incorporation.
